Speakers - BIOHK2022

‪CHAN Kin-Lic Garnet 陈建历‪

Bren Professor of Chemistry and Simons Investigator in Theoretical Physics, California Institute of Technology

DAI Xiao Chang 戴晓畅

Sirnaomics Executive Director / Scientific and Strategic Director

GUO Yike 郭毅可

Provost, The Hong Kong University of Science and Technology

KAWAGUCHI Lance

Chairman, Board of Directors, Asian Fund for Cancer Research

LAU Ming Chu, Edith 刘明珠

Chief Executive Officer, Hong Kong Center For Clinical Research

LEUNG Chun Ying 梁振英

Vice Chairman, National Committee of the Chinese People’s Political Consultative Conference

LO Yuk Ming, Dennis 卢煜明

Associate Dean (Research), Faculty of Medicine, The Chinese University of Hong Kong

LYU Ai Ping 吕爱平

Dean and Chair Professor, School of Chinese Medicine, Hong Kong Baptist University

MAK Tak Wah 麦德华

Director, Centre for Oncology and Immunology, The University of Hong Kong

TAI Xue Cheng 台雪成

Chief Research Scientist and Program Director, Hong Kong Centre For Cerebro-Cardiovascular Health Engineering, Hong Kong Science Park

TO Simon 杜志強

Executive Director and Chairman, HUTCHMED (China) Limited

YIU Wilfred 姚嘉仁

Chief Operating Officer & Co‐Head of Markets, Hong Kong Exchanges and Clearing Limited

YOUNG Wise 杨咏威

Chairman/Lab Director, Mononuclear Therapeutics Limited

YU Guo-Liang 余国良

Co-president, BIOHK2022; Chairman, Bayhelix; Co-founder, Executive Director, Chairman and Chief Executive Officer, Apollomics

HU Charles 胡正忠

Founder & CEO, Ryoden Medical & Transformation Biotechnology Entrepreneur

LIU Andy 劉安庭

President, Healthcare Division, BaseBit Technologies

National Committee Member, Chinese People’s Political Consultative Conference
Member, Legislative Council of The HKSAR
Member, Election Committee of The HKSAR
Managing Partner, Philip K.H. Wong, Kennedy Y.H. Wong & Co.

ANELLA Fabrizio Maria

Senior Research Scientist presso Taron Solutions Limited

BA Su Juan 巴素娟

President and CEO, National Foundation for Cancer Research

BIAN Zhaoxiang 卞兆祥

Associate Vice-President (Chinese Medicine Development) of HKBU

CHAN Ka-leung 陈家亮

Dean, Faculty of Medicine of The Chinese University of Hong Kong

CHAN Kar Lun Gallant 陳嘉倫

Founding Director and Principal Scientist

CHAN Kelvin 陈金泉

Professor, Liverpool John Moores Uni.

CHAN Sabrina

Senior Executive Director, Hong Kong Association of Pharmaceutical Industries

CHAN Wayne

Co-founder & CEO, Gutolution

CHAN Yannie 陈嘉茵

Qualified Patent and Trade Mark Attorney(AU, NZ), InCompass IP Ltd

CHAU Wilton 周志偉

Chairman, Pan Asia Venture Development Platform (PAVD)

CHAU Ying 周迎

Professor, Department of Chemical and Biological Engineering, The Hong Kong University of Science and Technology

CHE Jennifer

Vice President, Eagle IP Ltd

CHEN Andrew

Managing Director, Accenture

CHEN Joy

Partner, Family Enterprise and Family Office Advisory Services, Ernst & Young Global Limited

CHEN Ping

Co-president, BIOHK2022; Main founder, AusvicCapital

CHEN Scarlett

Managing Partner, Verge HealthTech Fund

CHENG Aifang 程爱芳

Research Assistant Professor, Department of Ocean Science, The Hong Kong University of Science and Technology

CHENG Gary

Vice President and Head of Asia Pacific – Health Advances

CHEUNG Wing Tak 張永德

Dr. Cheung Wing Tak, Family Doctor

CHIU Jenny 招展如

General Manager, Phase Scientific International Limited

CHOI Kevin

Business Development Manager – Public Sector, Amazon Web Services

DONG Dong 董咚

Assistant Professor, the JC School of Public Health and Primary Care, The Chinese University of Hong Kong

DONG Li 董利

Hongkong APX Capital Partner

FAN Rachel

CEO, G-NiiB GenieBiome

HO Chung Yin, Johnny 何颂贤

Associate Head (MSE), Department of Materials Science and Engineering, City University of Hong Kong

HONG Eugene

Executive Director, Head Pharmaceuticals and Healthcare at DBS Bank

HUI Emmanuel

CEO of Tiger Jade Pebble Accelerator

JIANG Gina 江宜蓁

Managing Director, Hong Kong Institute of Biotechnology (HKIB)

KWONG Thomas

Research scientist, Immuno Cure Holding (HK) Limited

LAI Chun Wan Jeffrey

Medical Laboratory Director, Asia Molecular Diagnostics Laboratory Limited

LAM Wallace

Deputy Head, Institutional Banking Group, DBS Hong Kong

LEE Edmund

General Manager & Head of Group ESG Initiatives, Gold Peak Technology Group Limited

LEE Wai Chung 李慧中

Chief Operating Officer at Sanomics Limited; Clinical Professional Consultant & Specialist in Medical Oncology, CUHK Medical Centre

LEE Woon Shiu

Board Member, DBS Foundation

LEUNG Chris

China Chief Economist, DBS Bank (HK)

LEUNG Christopher 梁启信

Chairperson and Clinical Professor, Department of Ophthalmology, The University of Hong Kong (HKU)

LI Ben

Founder and CEO, Heals Healthcare

LI Yongxin 李泳新

Assistant Professor, Department of Chemistry, Faculty of Science, HKU

LIU Andy 劉安庭

President, Healthcare Division, BaseBit Technologies

LIU Da 柳達

Managing Director, CR CP Life Science Fund

LIU Jianhui 刘建辉

Postdoctoral Fellow, The Chinese University of Hong Kong

LIU Xing

General Manager, BGI Health (HK) Company Limited

LIU Ying

Managing Partner at Tiger Jade Capital, LLP

LO Yuk Lam 盧毓琳

Chairman, Food and Environmental Hygiene, Food and Health Bureau, Government Secretariat HKSAR

LOO TY Wings

Medical Technologist, DNA Wecheck Limited

LUI Christopher 雷宇光

Managing Director at Jefferies leading the firm’s Asia (ex. Japan ex. Australia) healthcare equity research efforts

MA Libin

Senior Director Medical Affairs & Science Asia Pac at Labcorp Development (Asia) Pte. Ltd

NG Andrew

Managing Director and Head of Healthcare

NG Siewchien 黃秀娟

Assistant Dean (Development) Professor, Department of Medicine and Therapeutics, CUHK

PATERSON Mungo

Senior Director, Sales & Business Development, EVERSANA Asia Pte Ltd

PUN Frank

Head of HK Office at Insilico Medicine

SHAO Eric 邵文斌

VP & GM, IQVIA Commercial Solutions, Greater China

SHUM Winnie

Assistant Professor & Principal Investigator, School of Life Science and Technology, ShanghaiTech University

SIT Wing-hang 薛永恆

Former Secretary for Innovation and Technology

SONG Simone

Founder and Senior Partner of ORI Capital, manager of ORI Healthcare Funds

SORDO Luis Segovia

Director, Site Solutions APAC/ Hong Kong Office GMBA at Parexel

SUGIYAMA Haruo 杉山治夫

Professor, Graduate School of Medicine, Osaka University

SZYF Moshe

McGill Professor, Department of Pharmacology and Therapeutics, McGill University

TAM-ZAMAN Nuzhat

CEO, Sinoveda Canada Inc.

TANG C. Mark 唐馬克

Managing Director, Good Health Capital (New York)

TSAI Albert

Chief Medical Officer, Zhaoke Ophthalmology Ltd.

TSE Lung Fung 谢龙峰

Clinical Assistant Professor (Honorary), Department Of Orthopaedics & Traumatology Faculty Of Medicine, The Chinese University Of Hong Kong Chief Medical Director, KOLN3D Technology (Medical) Limited

TSE Samuel

Macro Research Economist, DBS Bank (HK)

TSUI Joseph 徐景清

Professor Emeritus, University of British Columbia

WONG Brian

Founder, Oxford Political Review

WONG Dixon

Head of Financial Services and Global Head of Family Office at Invest Hong Kong, HKSARG

WONG Edward

Regional Product Manager at GenScript Asia Pacific

WONG Kennedy 黄英豪

National Committee Member, Chinese People’s Political Consultative Conference
Member, Legislative Council of The HKSAR
Member, Election Committee of The HKSAR
Managing Partner, Philip K.H. Wong, Kennedy Y.H. Wong & Co.